Agilent Technologies.

‘We’ve aggressively constructed an LC/MS portfolio for the life sciences in recent years, and the Mass Profiler Professional software program provides the crucial ability to visualize biological pathways from the substantial and complex data units generated by metabolomics research.’.. Agilent Technologies, Stemina Biomarker Discovery to accelerate metobolomic research Agilent Technologies Inc. and Stemina Biomarker Discovery, Inc. Today announced efforts to accelerate Stemina’s metobolomic analysis. Stemina uses metabolomic analysis of stem cells for the discovery of biomarkers for use in drug screening and drug development.AF implicated in unexpected cardiac death By Caroline Price, Senior medwireNews Reporter Individuals who develop atrial fibrillation are at more than twice the usual risk for unexpected cardiac death , reveal US study findings published in JAMA Internal Medicine. A meta-analysis of the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study shows that AF was associated with a 2.5-fold increased risk for SCD in the general population.

You Might Also Like